Ongoing, recruitingTherapeutic use (Phase IV)Interventional

COPD - Eosinophil-guided Reduction of Inhaled Corticosteroids (COPERNICOS)

At a glance

Status

Ongoing, recruiting

Phase

Therapeutic use (Phase IV)

Sponsor

Gentofte Hospital, Frederiksberg Hospital

Enrolment target

444

Start

23 Aug 2022

Chronic obstructive pulmonary disease (COPD)

What is this study about?

Number of hospitalization-requiring exacerbations and/or death within 365 days.

Who may be eligible?

Age 18 Years to any · Sex: All

Locations (1)

—
Denmark

How to find out more

Official trial record

Always speak to your GP or specialist before deciding to take part in a study.

Discussion

Community discussion

Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.